Receiving a diagnosis of Hepatitis B can feel overwhelming. For many, the condition remains silent for years, while for others, it brings waves of fatigue, abdominal discomfort, or jaundice that disrupt daily life and drain physical energy. The uncertainty of living with a viral infection often brings emotional stress, specifically regarding long-term health and the safety of loved ones. Treatment is the key to navigating this uncertainty. It is essential not only for managing current symptoms but for protecting the liver from scarring (cirrhosis) and preventing serious complications like liver cancer. 

It is important to understand that not everyone with Hepatitis B needs medication immediately. Treatment needs vary significantly based on whether the infection is acute (short-term) or chronic (long-term), the level of virus in the blood, and the condition of the liver. While some people may only need regular monitoring, others require consistent therapy to keep the virus under control. 

Overview of treatment options for Hepatitis B 

The primary goal of Hepatitis B treatment is to suppress the replication of the virus. By keeping the viral load as low as possible often to undetectable levels, treatment reduces liver inflammation and halts the progression of liver damage. 

For acute Hepatitis B, medication is rarely necessary. The body’s immune system typically clears the infection on its own, and care focuses on rest, hydration, and proper nutrition. Chronic Hepatitis B, however, requires a different approach. Treatment is usually long-term, potentially lifelong, and relies heavily on antiviral medications. While lifestyle changes like avoiding alcohol and maintaining a healthy weight support liver health, they cannot stop the virus from replicating. Therefore, medication is the cornerstone of management for chronic cases. 

Medications used for Hepatitis B 

When treatment is indicated, doctors primarily prescribe oral antiviral drugs or immune-boosting injections. 

Nucleoside/Nucleotide Analogues: This class of oral antivirals is the standard first-line treatment for chronic Hepatitis B. Drugs such as entecavir and tenofovir are widely prescribed because they are potent, effective, and generally well-tolerated. These medications are taken as a daily pill. Clinical experience suggests that these drugs are highly effective at suppressing the virus in the vast majority of patients (AASLD, 2018). Patients can expect to continue these medications for several years or indefinitely. While they do not usually cure the infection, they effectively put the virus to “sleep,” preventing it from damaging the liver. 

Interferons Pegylated interferon: is an older treatment option administered via weekly injection. Unlike oral antivirals, it is taken for a finite period, typically 48 weeks. It is used less frequently today due to more noticeable side effects, but it may be considered for younger patients or specific cases where a finite treatment duration is preferred over lifelong pills. 

How these medications work 

The medications used to treat Hepatitis B tackle the virus from two different angles: blocking its ability to multiply or strengthening the body’s natural defenses. 

Nucleoside and nucleotide analogues act as “decoys.” The Hepatitis B virus needs to build new DNA copies of itself to survive and spread. These drugs mimic the building blocks the virus uses. When the virus tries to use the drug to build its DNA, the process is jammed, and replication stops. This lowers the amount of virus in the blood, giving the liver a chance to heal. 

Interferons work differently by simulating the body’s natural immune response. They signal the immune system to recognize and attack the infected liver cells more aggressively, helping to clear the virus. 

Side effects and safety considerations 

Modern oral antivirals are generally safe, but monitoring is still required. 

Oral antivirals (entecavir, tenofovir) typically cause mild side effects like nausea, headache, or dizziness. Long-term use of certain tenofovir requires monitoring for kidney and bone issues. 

Interferon injections often cause more significant side effects, including flu-like symptoms (fever, aches, chills), fatigue, and mood changes like depression or anxiety. 

Hepatitis B patients must not stop medication abruptly, as this can cause a viral “flare.” Always consult a healthcare provider before changes. Seek immediate care for signs of a severe allergic reaction or worsening liver symptoms (jaundice, dark urine). 

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care. 

References 

  1. Centers for Disease Control and Prevention. https://www.cdc.gov 
  1. Mayo Clinic. https://www.mayoclinic.org 
  1. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov 
  1. Hepatitis B Foundation. https://www.hepb.org 

Medications for Hepatitis B

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hepatitis B.

Found 7 Approved Drugs for Hepatitis B

Lamivudine

Brand Names
Cimduo, Combivir, Epzicom, Delstrigo, Dovato, SYMFI, Triumeq, Efavirenz, Abacavir, Epivir

Lamivudine

Brand Names
Cimduo, Combivir, Epzicom, Delstrigo, Dovato, SYMFI, Triumeq, Efavirenz, Abacavir, Epivir
Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg. Efavirenz, lamivudine and tenofovir disoproxil fumarate tablets are three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and lamivudine (3TC) and tenofovir disoproxil fumarate (TDF), both nucleo(t)side reverse transcriptase inhibitors and are indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg. ( 1 )

Viread

Generic Name
Tenofovir Disoproxil

Viread

Generic Name
Tenofovir Disoproxil
Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor. Tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older., Tenofovir disoproxil fumarate tablets are indicated for the treatment of chronic hepatitis B in adults and pediatric patients 12 years of age and older.

Baraclude

Generic Name
Entecavir

Baraclude

Generic Name
Entecavir
Entecavir tablets are indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. Entecavir is a hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. ( 1 )

Adefovir Dipivoxil

Generic Name
Adefovir Dipivoxil

Adefovir Dipivoxil

Generic Name
Adefovir Dipivoxil
Adefovir dipivoxil tablets are indicated for the treatment of chronic hepatitis B in patients 12 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. This indication is based on histological, virological, biochemical, and serological responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function. For patients 12 to less than 18 years of age, the indication is based on virological and biochemical responses in patients with HBeAg+ chronic hepatitis B virus infection with compensated liver function. Adefovir dipivoxil tablets are a nucleotide analogue indicated for the treatment of chronic hepatitis B in patients 12 years of age and older. ( 1 )

Tenofovir Alafenamide

Brand Names
Vemlidy, Prezcobix, Tybost

Tenofovir Alafenamide

Brand Names
Vemlidy, Prezcobix, Tybost
PREZCOBIX is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) in treatment-naïve and treatment-experienced adults and pediatric patients weighing at least 25 kg with no darunavir resistance-associated substitutions (V11I, V32I, L33F, I47V, I50V, I54L, I54M, T74P, L76V, I84V, L89V). PREZCOBIX is a two-drug combination of darunavir, a human immunodeficiency virus (HIV-1) protease inhibitor, and cobicistat, a CYP3A inhibitor, and is indicated for the treatment of HIV-1 in treatment-naïve and treatment-experienced adults and pediatric patients weighing at least 25 kg with no darunavir resistance-associated substitutions (V11I, V32I, L33F, I47V, I50V, I54L, I54M, T74P, L76V, I84V, L89V). ( 1 )
Showing 1-5 of 7
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances